CA SB1199

Prescription drug cost sharing.

Engrossed Senate Akilah Weber Pierson (D)
Plain English Summary

California SB1199 aims to regulate the costs associated with prescription drugs by establishing new requirements for health care coverage. It seeks to ensure that patients are not burdened with excessive out-of-pocket costs when obtaining necessary medications. The bill is designed to improve affordability and accessibility for those needing prescription drugs.

Supporters Say

Supporters of SB1199 would highlight it as a crucial step towards making healthcare more affordable for Californians. They would argue that the bill protects patients from high prescription drug costs, ultimately leading to better health outcomes and financial stability for families. This legislation represents a commitment to prioritize public health over corporate profits.

Critics Say

Critics of SB1199 might argue that the bill could lead to increased costs for insurance providers, which may ultimately be passed on to consumers in the form of higher premiums. They might also contend that the legislation could stifle innovation in the pharmaceutical industry by imposing too many regulations. Additionally, some may question whether the bill effectively addresses the root causes of high drug prices.

Legislative Votes
Do pass as amended and be re-referred to the Committee on [Appropriations]
A · Jun 30, 2026
Passed
13
YEA
0
NAY
Senate 3rd Reading SB1199 Weber Pierson
Senate · May 22, 2026
Passed
26
YEA
0
NAY
Do pass
Senate · May 14, 2026
Passed
5
YEA
0
NAY
Placed on suspense file
Senate · May 4, 2026
Passed
7
YEA
0
NAY
Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations]
Senate · Apr 22, 2026
Passed
9
YEA
0
NAY

Source: LegiScan roll call vote data.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the California State Legislature. Conflict-of-interest analysis for this bill is coming soon.